Literature DB >> 23708639

Vitamin D in the healthy European paediatric population.

Christian Braegger1, Cristina Campoy, Virginie Colomb, Tamas Decsi, Magnus Domellof, Mary Fewtrell, Iva Hojsak, Walter Mihatsch, Christian Molgaard, Raanan Shamir, Dominique Turck, Johannes van Goudoever.   

Abstract

In recent years, reports suggesting a resurgence of vitamin D deficiency in the Western world, combined with various proposed health benefits for vitamin D supplementation, have resulted in increased interest from health care professionals, the media, and the public. The aim of this position paper is to summarise the published data on vitamin D intake and prevalence of vitamin D deficiency in the healthy European paediatric population, to discuss the health benefits of vitamin D and to provide recommendations for the prevention of vitamin D deficiency in this population. Vitamin D plays a key role in calcium and phosphate metabolism and is essential for bone health. There is insufficient evidence from interventional studies to support vitamin D supplementation for other health benefits in infants, children, and adolescents. The pragmatic use of a serum concentration >50 nmol/L to indicate sufficiency and a serum concentration <25 nmol/L to indicate severe deficiency is recommended. Vitamin D deficiency occurs commonly among healthy European infants, children, and adolescents, especially in certain risk groups, including breast-fed infants, not adhering to the present recommendation for vitamin D supplementation, children and adolescents with dark skin living in northern countries, children and adolescents without adequate sun exposure, and obese children. Infants should receive an oral supplementation of 400 IU/day of vitamin D. The implementation should be promoted and supervised by paediatricians and other health care professionals. Healthy children and adolescents should be encouraged to follow a healthy lifestyle associated with a normal body mass index, including a varied diet with vitamin D-containing foods (fish, eggs, dairy products) and adequate outdoor activities with associated sun exposure. For children in risk groups identified above, an oral supplementation of vitamin D must be considered beyond 1 year of age. National authorities should adopt policies aimed at improving vitamin D status using measures such as dietary recommendations, food fortification, vitamin D supplementation, and judicious sun exposure, depending on local circumstances.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708639     DOI: 10.1097/MPG.0b013e31828f3c05

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  120 in total

1.  25-hydroxyvitamin D serum level in children of different ethnicity living in Italy.

Authors:  Bruna Franchi; Michele Piazza; Marco Sandri; Laura Tenero; Pasquale Comberiati; Attilio Loris Boner; Carlo Capristo
Journal:  Eur J Pediatr       Date:  2014-11-15       Impact factor: 3.183

Review 2.  Vitamin D in childhood and adolescence: an expert position statement.

Authors:  Giuseppe Saggese; Francesco Vierucci; Annemieke M Boot; Justyna Czech-Kowalska; Giovanna Weber; Carlos A Camargo; Eric Mallet; Margherita Fanos; Nick J Shaw; Michael F Holick
Journal:  Eur J Pediatr       Date:  2015-04-02       Impact factor: 3.183

Review 3.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

4.  Vitamin D in European children-statement from the European Academy of Paediatrics (EAP).

Authors:  Zachi Grossman; Adamos Hadjipanayis; Tom Stiris; Stefano Del Torso; Jean-Christophe Mercier; Arunas Valiulis; Raanan Shamir
Journal:  Eur J Pediatr       Date:  2017-04-12       Impact factor: 3.183

5.  A Belgian consensus-statement on growing-up milks for children 12-36 months old.

Authors:  Yvan Vandenplas; Nadine De Ronne; Annemie Van De Sompel; Koen Huysentruyt; Martine Robert; Jacques Rigo; Isabelle Scheers; Daniel Brasseur; P Goyens
Journal:  Eur J Pediatr       Date:  2014-04-25       Impact factor: 3.183

6.  Is high oily fish intake achievable and how does it affect nutrient status in 8-9-year-old children?: the FiSK Junior trial.

Authors:  Stine Vuholm; Marie N Teisen; Nanna Glent Buch; Ken D Stark; Jette Jakobsen; Christian Mølgaard; Lotte Lauritzen; Camilla T Damsgaard
Journal:  Eur J Nutr       Date:  2019-05-09       Impact factor: 5.614

7.  Executive summary: Evaluating the evidence base to support the inclusion of infants and children from birth to 24 mo of age in the Dietary Guidelines for Americans--"the B-24 Project".

Authors:  Daniel J Raiten; Ramkripa Raghavan; Alexandra Porter; Julie E Obbagy; Joanne M Spahn
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

8.  Effect of Vitamin D Supplementation, Food Fortification, or Bolus Injection on Vitamin D Status in Children Aged 2-18 Years: A Meta-Analysis.

Authors:  Neil R Brett; Nathalie Gharibeh; Hope A Weiler
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

9.  Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hanne Hauger; Rikke Pilmann Laursen; Christian Ritz; Christian Mølgaard; Mads Vendelbo Lind; Camilla Trab Damsgaard
Journal:  Eur J Nutr       Date:  2020-02-14       Impact factor: 5.614

Review 10.  Vitamin D insufficiency and insulin resistance in obese adolescents.

Authors:  Catherine A Peterson; Aneesh K Tosh; Anthony M Belenchia
Journal:  Ther Adv Endocrinol Metab       Date:  2014-12       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.